Literature DB >> 21117375

Is the eradication of tuberculosis 'yesterday's ambition' or 'tomorrow's triumph'?

Alimuddin Zumla1, John M Grange.   

Abstract

Tuberculosis (TB) remains a serious infectious disease continuing to cause around 1.8 million deaths annually. The great paradox is that despite the availability of effective treatment for the past 60 years, it continues to spread relentlessly, particularly in sub-Saharan Africa due to the fuelling effect of the HIV/AIDS epidemic. It is no longer a medical epidemic, but an epidemic of injustice. Increased political and financial investment by the industrially developed nations, as well as sustained political will in the affected countries, is required to bring TB under control. It is imperative that the control should be linked to that of HIV which is also closely associated with poverty, poor housing and malnutrition. The historical, social, philosophical and political perspectives that may have influenced the failure of TB control are discussed. Once again, therefore, the question is raised--can TB be brought under control?

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21117375      PMCID: PMC4952404          DOI: 10.7861/clinmedicine.10-5-450

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  8 in total

1.  Historical declines in tuberculosis: nature, nurture and the biosocial model.

Authors:  J M Grange; M Gandy; P Farmer; A Zumla
Journal:  Int J Tuberc Lung Dis       Date:  2001-03       Impact factor: 2.373

2.  The U-shaped curve of concern.

Authors:  L B Reichman
Journal:  Am Rev Respir Dis       Date:  1991-10

Review 3.  Tuberculosis in developing countries: burden, intervention and cost.

Authors:  C J Murray; K Styblo; A Rouillon
Journal:  Bull Int Union Tuberc Lung Dis       Date:  1990-03

4.  The inverse care law.

Authors:  J T Hart
Journal:  Lancet       Date:  1971-02-27       Impact factor: 79.321

Review 5.  Tuberculosis elimination--what's to stop us?

Authors:  L B Reichman
Journal:  Int J Tuberc Lung Dis       Date:  1997-02       Impact factor: 2.373

6.  A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death.

Authors:  Y Ahmed; P Mwaba; C Chintu; J M Grange; A Ustianowski; A Zumla
Journal:  Int J Tuberc Lung Dis       Date:  1999-08       Impact factor: 2.373

Review 7.  Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.

Authors:  Abigail Wright; Matteo Zignol; Armand Van Deun; Dennis Falzon; Sabine Ruesch Gerdes; Knut Feldman; Sven Hoffner; Francis Drobniewski; Lucia Barrera; Dick van Soolingen; Fadila Boulabhal; C N Paramasivan; Kai Man Kam; Satoshi Mitarai; Paul Nunn; Mario Raviglione
Journal:  Lancet       Date:  2009-04-15       Impact factor: 79.321

8.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

  8 in total
  1 in total

1.  Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.

Authors:  Francine Ntoumi; Eskild Petersen; Peter Mwaba; Eleni Aklillu; Sayoki Mfinanga; Dorothy Yeboah-Manu; Markus Maeurer; Alimuddin Zumla
Journal:  Int J Infect Dis       Date:  2022-03-14       Impact factor: 3.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.